Company profile LBPH
After 39 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 52 days it will total up to 96.0. Longboard Pharmaceuticals expected interest is significantly higher compared to same quarter last year (+113.3%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 7 | 85 1114.3% QoQ | 0 -100.0% QoQ | 0 -100.0% QoQ |
| 2020 | 7 0.0% YoY inf% QoQ | 56 -34.1% YoY 700.0% QoQ | 45 inf% YoY -19.6% QoQ | 60 inf% YoY 33.3% QoQ |
| 2021 | 44 528.6% YoY -26.7% QoQ | 45 -19.6% YoY 2.3% QoQ | 88 95.6% YoY 95.6% QoQ | 40 -33.3% YoY -54.5% QoQ |
| 2022 | 37 -15.9% YoY -7.5% QoQ | 43 -4.4% YoY 16.2% QoQ | 42 -52.3% YoY -2.3% QoQ | 68 70.0% YoY 61.9% QoQ |
| 2023 | 45 21.6% YoY -33.8% QoQ | 73 69.8% YoY 62.2% QoQ | 42 0.0% YoY -42.5% QoQ | 130 91.2% YoY 209.5% QoQ |
| 2024 | 41 -8.9% YoY -68.5% QoQ | - | - | - |
The average 5 years interest of Longboard Pharmaceuticals was 3.82 per week. The last year interest of Longboard Pharmaceuticals compared to the last 5 years has changed by 53.66%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 208.95%.
There is not enough data for Longboard Pharmaceuticals LP352 to provide analysis
There is not enough data for Longboard Pharmaceuticals LP352 to provide correlation calculation
There is not enough data for Longboard Pharmaceuticals LP352 to provide analysis
There is not enough data for LP352 clinical trial to provide analysis
There is not enough data for LP352 clinical trial to provide correlation calculation
There is not enough data for LP352 clinical trial to provide analysis
There is not enough data for seizures associated with developmental and epileptic encephalopathies to provide analysis
There is not enough data for seizures associated with developmental and epileptic encephalopathies to provide correlation calculation
There is not enough data for seizures associated with developmental and epileptic encephalopathies to provide analysis
There is not enough data for Longboard Pharmaceuticals LP659 to provide analysis
There is not enough data for Longboard Pharmaceuticals LP659 to provide correlation calculation
There is not enough data for Longboard Pharmaceuticals LP659 to provide analysis
There is not enough data for multiple neurological diseases to provide analysis
There is not enough data for multiple neurological diseases to provide correlation calculation
There is not enough data for multiple neurological diseases to provide analysis
There is not enough data for Longboard Pharmaceuticals LP143 to provide analysis
There is not enough data for Longboard Pharmaceuticals LP143 to provide correlation calculation
There is not enough data for Longboard Pharmaceuticals LP143 to provide analysis
There is not enough data for Longboard Pharmaceuticals LP352 license agreement to provide analysis
There is not enough data for Longboard Pharmaceuticals LP352 license agreement to provide correlation calculation
There is not enough data for Longboard Pharmaceuticals LP352 license agreement to provide analysis
There is not enough data for Longboard Pharmaceuticals LP659 license agreement to provide analysis
There is not enough data for Longboard Pharmaceuticals LP659 license agreement to provide correlation calculation
There is not enough data for Longboard Pharmaceuticals LP659 license agreement to provide analysis
There is not enough data for Longboard Pharmaceuticals LP143 license agreement to provide analysis
There is not enough data for Longboard Pharmaceuticals LP143 license agreement to provide correlation calculation
There is not enough data for Longboard Pharmaceuticals LP143 license agreement to provide analysis